Outset Medical Inc. Common Stock (OM)
Stock · NASDAQ · Health Care
$3.95as of 10/16/2026
Price chart
Active signals
OM Signal Track Record
How signals performed across all stocks →What OM's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 38 | -11.0% | 32% | September 24, 2026 |
| Bollinger Band Breakout | 26 | -4.6% | 35% | October 1, 2026 |
| Bollinger Band Breakdown | 22 | -4.1% | 27% | May 8, 2026 |
| 200-Day Moving Average TouchActive now | 9 | -3.0% | 44% | October 6, 2026 |
| Any 20-session window (baseline) | -3.0% | 46% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About OM
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumabl…
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Employees
- 310
- Website
- outsetmedical.com/
Fundamentals
- 1-day range
- $3.81$4.11
- Market cap
- $96.39M
- P/E (trailing)
- —
- P/E (forward)
- -1.78
- EPS (trailing)
- $-4.08
- Dividend yield
- —
- Beta
- 2.01
- Avg. volume
- 154.1K
How Outset Medical Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 13, 2026 · via SEC EDGAR / Finnhub
Forecasts
3 analyst ratings
Outset Medical Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- OMOutset Medical Inc. Common Stock$3.94▼ 3.43%Market cap $96.39MP/E —$2.84$15.94
- HYPRHyperfine Inc. Class A Common Stock$0.755▼ 3.21%Market cap $97.48MP/E —$0.7536$2.22
- HSDTSolana Company Class A Common Stock (DE)$2.24▼ 4.68%Market cap $98.09MP/E —$1.19$16.81
- NRXSNeuraxis Inc. Common Stock$7.7▼ 0.52%Market cap $86.47MP/E —$2.21$9.33
- VANIVivani Medical Inc. Common Stock (DE)$1.12▼ 2.61%Market cap $117.28MP/E —$0.9227$1.92
- STEXStreamex Corp. Common Stock$0.374▼ 8.33%Market cap $75.35MP/E —$0.3876$6.5
- ECORelectroCore Inc. Common Stock$7.85▼ 5.99%Market cap $60.41MP/E —$4.41$12.7
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| OM Outset Medical Inc. Common Stock | $96.39M | — | $3.94 | ▼ 3.43% | $2.84$15.94 |
| HYPR Hyperfine Inc. Class A Common Stock | $97.48M | — | $0.755 | ▼ 3.21% | $0.7536$2.22 |
| HSDT Solana Company Class A Common Stock (DE) | $98.09M | — | $2.24 | ▼ 4.68% | $1.19$16.81 |
| NRXS Neuraxis Inc. Common Stock | $86.47M | — | $7.7 | ▼ 0.52% | $2.21$9.33 |
| VANI Vivani Medical Inc. Common Stock (DE) | $117.28M | — | $1.12 | ▼ 2.61% | $0.9227$1.92 |
| STEX Streamex Corp. Common Stock | $75.35M | — | $0.374 | ▼ 8.33% | $0.3876$6.5 |
| ECOR electroCore Inc. Common Stock | $60.41M | — | $7.85 | ▼ 5.99% | $4.41$12.7 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Full Transcript: Outset Medical Q2 2026 Earnings Callbenzinga · 10/12/2026
- Here's Why You Should Retain DaVita Stock in Your Portfolio for NowYahoo · 10/9/2026
- Reasons to Retain Hims & Hers Stock in Your Portfolio for NowYahoo · 10/8/2026
Insider Activity
Insider Actions →- Braden Michael Leonard · October 2, 2026 · Buy16.6K @ $3.88
- Braden Michael Leonard · October 1, 2026 · Buy228.3K @ $3.53
- John L. Brottem · August 17, 2026 · Sale2.6K @ $4.39
- Renee Gaeta · August 17, 2026 · Sale4.5K @ $4.39
- Leslie Trigg · August 17, 2026 · Sale3.4K @ $4.39
- Kevin C. Oboyle · June 4, 2026 · Grant10.7K
- Karen Prange · June 4, 2026 · Grant10.7K
- Brent D. Lang · June 4, 2026 · Grant10.7K
- Karen Drexler · June 4, 2026 · Grant10.7K
- Patrick T. Hackett · June 4, 2026 · Grant10.7K
- D. Keith Grossman · June 4, 2026 · Grant10.7K
- Renee Gaeta · June 3, 2026 · Sale17.7K @ $4.94
- Marc Nash · May 15, 2026 · Sale1.6K @ $3.7
- John L. Brottem · May 15, 2026 · Sale2.6K @ $3.7
- Leslie Trigg · May 15, 2026 · Sale3.4K @ $3.7
Institutional Ownership
March 31, 2026
- Total shares held
- 15.20M
- Total value held
- $57.99M
- Institutional holders
- 93
- Unknown2.74M
- Unknown1.90M
- Unknown1.26M
- Unknown949.4K
- Unknown833.3K
- Unknown808.3K
- Unknown763.8K
- Unknown594.6K
- Unknown526.6K
- Unknown504.1K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Hims & Hers news mentioned in broader market context
Recent coverage from Yahoo discusses reasons to retain Hims & Hers stock, which shares the digital health sector with Outset Medical. While the article focuses on a different company, it highlights ongoing investor interest in the broader telehealth and digital medicine space. Outset Medical remains a high-beta stock with significant volatility, as seen in its wide 52-week range.
Hims & Hers news mentioned in broader market context. Recent coverage from Yahoo discusses reasons to retain Hims & Hers stock, which shares the digital health sector with Outset Medical. While the article focuses on a different company, it highlights ongoing investor interest in the broader telehealth and digital medicine space. Outset Medical remains a high-beta stock with significant volatility, as seen in its wide 52-week range.